Zhuoxin Sun

13.0k citations

91 papers · 5.6k indexed · 4 hit papers · h-index 29

Molecular Biology top 5%
Hematology top 0.5%
Cellular and Molecular Neuroscience top 1%
Oncology top 5%
Cognitive Neuroscience top 2%

Co-authors: Allan R. Sampson David A. Lewis Joseph N. Pierri Martin S. Tallman Takanori Hashimoto Elisabeth Paietta Mark R. Litzow Stephen M. Eggan
Topics: Acute Myeloid Leukemia Research (42 papers)Acute Lymphoblastic Leukemia research (13 papers)Histone Deacetylase Inhibitors Research (11 papers)
Cited by: Hematology Biological Psychiatry Cellular and Molecular Neuroscience
Journals: New England Journal of Medicine Journal of Clinical Oncology Journal of Neuroscience
Partner nations: United States Israel Switzerland

In The Last Decade

Zhuoxin Sun

83 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia

2003 751 citations Takanori Hashimoto, Joseph N. Pierri et al. Journal of Neuroscience profile →
Anthracycline Dose Intensification in Acute Myeloid Leukemia

2009 639 citations Hugo F. Fernández, Zhuoxin Sun et al. profile →
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models

2006 586 citations Michelle Day, Zhongfeng Wang et al. Nature Neuroscience profile →
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

2016 378 citations Marco Colleoni, Zhuoxin Sun et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Zhuoxin Sun

Since Specialization

Citations

This map shows the geographic impact of Zhuoxin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuoxin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuoxin Sun more than expected).

Fields of papers citing papers by Zhuoxin Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuoxin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuoxin Sun. The network helps show where Zhuoxin Sun may publish in the future.

Co-authorship network of co-authors of Zhuoxin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuoxin Sun. A scholar is included among the top collaborators of Zhuoxin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuoxin Sun. Zhuoxin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Additions and subtractions of radiotherapy in patients with oligometastatic non-small cell lung cancer under the era of immunotherapy 2025 ·Critical Reviews in Oncology/Hematology ·Zhuoxin Sun,Jun Wen,Wenxing Cui,(unknown),(unknown),Xiangjiao Meng	0
2	IgG-Associated Hypocomplementemia in Neonatal Lupus: A Retrospective Multicenter Study 2025 ·Journal of Inflammation Research ·(unknown),Yihui Li,(unknown),(unknown),Huiwen Li,(unknown),Lily Li,Jinhui Hu,Jie Huo,Zhuoxin Sun,(unknown),Mengzhao Li,(unknown),Xueping Zhu	0
3	A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A Myelomatch Treatment Trial: ECOG-ACRIN MM20A-EA02 2024 ·Blood ·Jessica K. Altman,Zhuoxin Sun,Alexander E. Perl,Richard F. Little,Steven D. Gore,Laura C. Michaelis,Geoffrey L. Uy,Yasmin Abaza,Sameem Abedin,John L. Reagan,Ehab Atallah,Selina M. Luger,Mark R. Litzow	3
4	Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer 2024 ·The Oncologist ·David E. Gerber,Yating Wang,Suresh S. Ramalingam,Sheena Bhalla,Zhuoxin Sun,Hossein Borghaei,Julie R. Brahmer,Joan H. Schiller	0
5	Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling 2022 ·Leukemia Research ·Chezi Ganzel,Zhuoxin Sun,Timour Baslan,Yanming Zhang,Mithat Gönen,Omar Abdel‐Wahab,Janis Racevskis,Francine E. Garrett-Bakelman,Scott W. Lowe,Hugo F. Fernández,Rhett P. Ketterling,Selina M. Luger,Mark R. Litzow,Hillard M. Lazarus,Jacob M. Rowe,Martin S. Tallman,Ross L. Levine,Elisabeth Paietta	5
6	A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181 2022 ·Clinical Lung Cancer ·(unknown),Zhuoxin Sun,Bonnie Ky,Jenica Upshaw,Thomas J. FitzGerald,Max Diehn,Christine M. Lovly,Chandra P. Belani,Kurt R. Oettel,Gregory A. Masters,Matthew M. Harkenrider,Helen J. Ross,Suresh S. Ramalingam,Nathan A. Pennell	3
7	Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia 2021 ·British Journal of Haematology ·Peter H. Wiernik,Zhuoxin Sun,Larry D. Cripe,Jacob M. Rowe,Hugo F. Fernández,Selina M. Luger,Hillard M. Lazarus,Elisabeth Paietta,Martin S. Tallman,Mark R. Litzow	6
8	Alternatives to the Kaplan–Meier estimator of progression-free survival 2020 ·The International Journal of Biostatistics ·Jenny J. Zhang,Zhuoxin Sun,Han Yuan,Molin Wang	2
9	Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study 2019 ·Blood ·James M. Foran,Zhuoxin Sun,David F. Claxton,Hillard M. Lazarus,Daniel A. Arber,Jacob M. Rowe,Elisabeth Paietta,Janis Racevskis,Jessica K. Altman,Selina M. Luger,Aref Al‐Kali,Hong Zheng,Keith W. Pratz,E. Randolph Broun,Bayard L. Powell,Kristen M. O’Dwyer,John E. Godwin,Yishai Ofran,Mark R. Litzow,Martin S. Tallman	24
10	FLT3-ITD Mutations Are Prevalent and Significantly Impact Outcome after Intensive Therapy in Elderly Adults with Acute Myeloid Leukemia (AML): Analysis of the North American Intergroup E2906 Phase III Trial in Patients Age ≥60 Years 2018 ·Blood ·James M. Foran,Zhuoxin Sun,Elisabeth Paietta,Janis Racevskis,David F. Claxton,Hillard M. Lazarus,Daniel A. Arber,Jacob M. Rowe,John E. Godwin,Yanming Zhang,Martin S. Tallman,Mark R. Litzow,Keith W. Pratz,Selina M. Luger	4
11	A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia 2016 ·JCI Insight ·Marlise R. Luskin,Phyllis A. Gimotty,Catherine Smith,Alison W. Loren,María E. Figueroa,(unknown),Zhuoxin Sun,Martin S. Tallman,Elisabeth Paietta,Mark R. Litzow,Ari Melnick,Ross L. Levine,Hugo F. Fernández,Selina M. Luger,Martin Carroll,Stephen R. Master,Gerald Wertheim	18
12	Azacitidine with or without Entinostat for the treatment of therapy‐related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study 2015 ·British Journal of Haematology ·Thomas Prébet,Zhuoxin Sun,Rhett P. Ketterling,Amer M. Zeidan,Peter L. Greenberg,James G. Herman,Mark Juckett,Mitchell R. Smith,(unknown),Elisabeth Paietta,Magdalena Czader,María E. Figueroa,Janice Gabrilove,Harry P. Erba,Martin S. Tallman,Mark R. Litzow,Steven D. Gore,(unknown)	56
13	Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: Effect of specimen source (bone marrow or peripheral blood) on assay readouts 2012 ·Cytometry Part B Clinical Cytometry ·Alessandra Cesano,David B. Rosen,(unknown),Santosh Putta,Urte Gayko,David C. Spellmeyer,Larry D. Cripe,Zhuoxin Sun,Hajime Uno,Mark R. Litzow,Martin S. Tallman,Elisabeth Paietta	23
14	Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial 2010 ·The Breast ·Kelly‐Anne Phillips,Karin Ribi,Zhuoxin Sun,Alisa Stephens,Alastair M. Thompson,Vernon Harvey,Beat Thürlimann,Fátima Cardoso,Olivia Pagani,Alan S. Coates,Aron Goldhirsch,Karen N. Price,Richard D. Gelber,Jürg Bernhard	66
15	Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial 2010 ·Breast Cancer Research and Treatment ·Kelly‐Anne Phillips,Julie Aldridge,Karin Ribi,Zhuoxin Sun,Alastair M. Thompson,Vernon Harvey,Beat Thürlimann,Fátima Cardoso,Olivia Pagani,Alan S. Coates,Aron Goldhirsch,Karen N. Price,Richard D. Gelber,Jürg Bernhard	51
16	Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial 2007 ·Journal of Clinical Oncology ·Henning T. Mouridsen,Aparna Keshaviah,Alan S. Coates,Manuela Rabaglio,Monica Castiglione‐Gertsch,Zhuoxin Sun,Beat Thürlimann,L. Mauriac,John Forbes,Robert Paridaens,Richard D. Gelber,Marco Colleoni,Ian Smith,Karen N. Price,Aron Goldhirsch	93
17	Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease modelsbreakdown → 2006 ·Nature Neuroscience ·Michelle Day,Zhongfeng Wang,Jun Ding,(unknown),C.A. Ingham,(unknown),David L. Wokosin,Ema Ilijić,Zhuoxin Sun,Allan R. Sampson,Enrico Mugnaini,Ariel Y. Deutch,Susan R. Sesack,Gordon W. Arbuthnott,D. James Surmeier	586
18	Anatomical Evidence of Impaired Feedforward Auditory Processing in Schizophrenia 2006 ·Biological Psychiatry ·Robert A. Sweet,Sarah E. Bergen,Zhuoxin Sun,(unknown),Allan R. Sampson,David A. Lewis	67
19	Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia 2005 ·Journal of Neuroscience ·Takanori Hashimoto,Sarah E. Bergen,Quyen Le Nguyen,Baoji Xu,Lisa M. Monteggia,Joseph N. Pierri,Zhuoxin Sun,Allan R. Sampson,David A. Lewis	322
20	TheTlxGene Regulates the Timing of Neurogenesis in the Cortex 2004 ·Journal of Neuroscience ·(unknown),(unknown),Qiang Wu,Zhuoxin Sun,Dagmar Bock,Günther Schütz,(unknown),A. Paula Monaghan	123

About Zhuoxin Sun

Zhuoxin Sun is a scholar working on Hematology, Genetics and Cancer Research, having authored 91 papers that have together received 5.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (13 papers) and Histone Deacetylase Inhibitors Research (11 papers). The work is most often cited by research in Hematology (1.6k citations), Biological Psychiatry (334 citations) and Cellular and Molecular Neuroscience (1.6k citations). Zhuoxin Sun has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Allan R. Sampson, David A. Lewis, Joseph N. Pierri, Martin S. Tallman, Takanori Hashimoto, Elisabeth Paietta, Mark R. Litzow, Stephen M. Eggan, David W. Volk and Károly Mirnics. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact